Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID B PAGE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1922241140
CMS profile
475427
Location
PORTLAND, OR

General Payments · PY2018–2024

$233,545.11

  • Reported across 263 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$24,496.01

44 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $19,850.00 7
Travel and Lodging $2,278.00 8
Food and Beverage $1,584.87 21
Long term medical supply or device loan $598.20 6
Education $184.94 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $8,262.16 17
Genentech USA, Inc. $7,928.76 5
NOVARTIS PHARMACEUTICALS CORPORATION $2,761.70 9
Merck Sharp & Dohme Corporation $2,745.00 1
Daiichi Sankyo Inc. $1,665.00 2
Acerta Pharma LLC $792.54 4
Astellas Pharma US Inc $184.94 2
Stemline Therapeutics Inc. $63.20 1
PFIZER INC. $46.99 2
Genentech, Inc. $45.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $36,331.23 41
PY2019 $45,283.96 51
PY2020 $8,353.58 8
PY2021 $52,310.88 40
PY2022 $47,622.22 51
PY2023 $19,147.23 28
PY2024 $24,496.01 44

Payment records · PY2024 (44)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $84.99 03/08/2024 Education Undisputed 01/23/2026 1139345810 CMS
Astellas Pharma US Inc $99.95 03/08/2024 Education Undisputed 01/23/2026 1139346578 CMS
AstraZeneca Pharmaceuticals LP $118.25 04/16/2024 Food and Beverage Undisputed 01/23/2026 1105684207 CMS
AstraZeneca Pharmaceuticals LP $97.93 06/02/2024 Food and Beverage Undisputed 01/23/2026 1104753236 CMS
AstraZeneca Pharmaceuticals LP $555.00 06/19/2024 Consulting Fee Undisputed 01/23/2026 1105406251 CMS
AstraZeneca Pharmaceuticals LP $21.36 12/12/2024 Food and Beverage Undisputed 01/23/2026 1104360783 CMS
Daiichi Sankyo Inc. $1,387.50 07/17/2024 Consulting Fee Undisputed 01/23/2026 1089465594 CMS
Daiichi Sankyo Inc. $277.50 12/19/2024 Consulting Fee Undisputed 01/23/2026 1089465598 CMS
Genentech USA, Inc. $202.05 02/29/2024 Food and Beverage Undisputed 01/23/2026 1132998399 CMS
Genentech USA, Inc. $357.42 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1132998403 CMS
Genentech USA, Inc. $82.25 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1132998407 CMS
Genentech USA, Inc. $447.04 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1132998411 CMS
Genentech USA, Inc. $6,840.00 02/29/2024 Consulting Fee Undisputed 01/23/2026 1132998415 CMS
Genentech, Inc. $45.72 12/13/2024 Food and Beverage Undisputed 01/23/2026 1132998395 CMS
Gilead Sciences, Inc. $45.48 06/01/2024 Food and Beverage Undisputed 01/23/2026 1133833548 CMS
Gilead Sciences, Inc. $92.26 06/01/2024 Food and Beverage Undisputed 01/23/2026 1133833550 CMS
Gilead Sciences, Inc. $143.00 06/20/2024 Travel and Lodging Undisputed 01/23/2026 1133870112 CMS
Gilead Sciences, Inc. $297.53 06/20/2024 Travel and Lodging Undisputed 01/23/2026 1133870114 CMS
Gilead Sciences, Inc. $812.21 06/20/2024 Travel and Lodging Undisputed 01/23/2026 1133870116 CMS
Gilead Sciences, Inc. $21.14 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133833552 CMS
Gilead Sciences, Inc. $28.86 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133833554 CMS
Gilead Sciences, Inc. $49.99 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133833556 CMS
Gilead Sciences, Inc. $52.38 06/21/2024 Food and Beverage Undisputed 01/23/2026 1133833558 CMS
Gilead Sciences, Inc. $133.95 06/22/2024 Food and Beverage Undisputed 01/23/2026 1133833560 CMS
Gilead Sciences, Inc. $6,020.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 1133600175 CMS
Gilead Sciences, Inc. $86.15 07/09/2024 Food and Beverage Undisputed 01/23/2026 1133833562 CMS
Gilead Sciences, Inc. $109.30 07/09/2024 Travel and Lodging Undisputed 01/23/2026 1133870118 CMS
Gilead Sciences, Inc. $130.71 08/23/2024 Food and Beverage Undisputed 01/23/2026 1133833564 CMS
Gilead Sciences, Inc. $65.92 09/12/2024 Food and Beverage Undisputed 01/23/2026 1133833566 CMS
Gilead Sciences, Inc. $34.08 11/18/2024 Food and Beverage Undisputed 01/23/2026 1133833568 CMS
Gilead Sciences, Inc. $139.20 11/18/2024 Food and Beverage Undisputed 01/23/2026 1133833570 CMS
Merck Sharp & Dohme LLC $2,745.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 1141590988 CMS
Novartis Pharmaceuticals Corporation $2,025.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1087294443 CMS
Novartis Pharmaceuticals Corporation $45.41 06/03/2024 Food and Beverage Undisputed 01/23/2026 1087294445 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087294457 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087294453 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087294455 CMS
Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087294465 CMS
Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087294463 CMS
Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087294471 CMS
Novartis Pharmaceuticals Corporation $93.09 12/11/2024 Food and Beverage Undisputed 01/23/2026 1087294469 CMS
PFIZER INC. $17.74 01/12/2024 Food and Beverage Undisputed 01/23/2026 1131469589 CMS
PFIZER INC. $29.25 01/12/2024 Travel and Lodging Undisputed 01/23/2026 1131470737 CMS
Stemline Therapeutics Inc. $63.20 08/20/2024 Food and Beverage Undisputed 01/23/2026 1142959320 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.